Daclatasvir–sofosbuvir combination therapy with or without ribavirin for hepatitis C virus infection: from the clinical trials to real life

Pol S, Corouge M, Vallet-Pichard A

Hepatic Medicine: Evidence and Research 2016, 8:21-26

Published Date: 4 March 2016